现病史 | | | | | | | 是否有专业临床指南？是的。 指南的证据强度(差，好，很好，非常好)：好，根据共识 根据年龄，吸烟史，肺结节的大小，部位等，肺癌的可能性： 5-10% | | CT随访，3-6个月一次，然后9-12个月，如果未改变，24个月。 |
【参考文献】 Woloshin S, Schwartz LM, Dann E, Black WC. Using radiology reports to encourage evidence-based practice in the evaluation of small, incidentally detected pulmonary nodules. A preliminary study.Ann Am Thorac Soc. 2014 Feb;11(2):211-4. doi: 10.1513/AnnalsATS.201307-242BC. Pinsky PF, Gierada DS, Black W, et al. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med 2015;162:485-491. NCCN Clinical Practice Guidelines in Oncology. Lung Cancer Screening. 2021. Version 1. LCS-1 NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer. 2021. Version 5. PREV‐1 ACCP. Diagnosis and Management of Lung Cancer,3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 2013 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会 (CSCO) 非小细胞肺癌诊疗指南. 2020. ACCP. Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?Evaluation of Individuals With Pulmonary Nodules: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2013;143(5_suppl):e93S-e120S. doi:10.1378/chest.12-2351 Veronesi G，Bellomi M，Mulshine JL，et a1．Lung cancer screening with low-dose computed tomography：a non-invasive diagnostic protocol for baseline lung nodules[J]．Lung Cancer，2008，61(3)：340-349．doi：10．1016/j．1ungcan．2008．01．001． | 
